Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancreatic and gastric ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Gastric Cancer
• Ovarian Cancer
• Ovarian Epithelial Cancer
• Ovarian Germ Cell Tumor
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach | Phase 1 | Status: TERMINATED